309 related articles for article (PubMed ID: 18946753)
1. Androgen receptor expression in breast cancer: relationship with clinicopathological factors and biomarkers.
Ogawa Y; Hai E; Matsumoto K; Ikeda K; Tokunaga S; Nagahara H; Sakurai K; Inoue T; Nishiguchi Y
Int J Clin Oncol; 2008 Oct; 13(5):431-5. PubMed ID: 18946753
[TBL] [Abstract][Full Text] [Related]
2. Apocrine carcinoma as triple-negative breast cancer: novel definition of apocrine-type carcinoma as estrogen/progesterone receptor-negative and androgen receptor-positive invasive ductal carcinoma.
Tsutsumi Y
Jpn J Clin Oncol; 2012 May; 42(5):375-86. PubMed ID: 22450930
[TBL] [Abstract][Full Text] [Related]
3. Expression of androgen receptor in primary breast carcinoma and its relation with clinicopathologic features, estrogen, progesterone, and her-2 receptor status.
Vellaisamy G; Tirumalae R; Inchara YK
J Cancer Res Ther; 2019; 15(5):989-993. PubMed ID: 31603099
[TBL] [Abstract][Full Text] [Related]
4. [Expression of androgen receptor in breast carcinoma and its relationship with estrogen receptor, progesterone receptor and HER2 status].
Chen J; Zhang X; Tian R; Liu Y; Dong HM; Guo RF; Liang HY
Zhonghua Bing Li Xue Za Zhi; 2010 Nov; 39(11):743-6. PubMed ID: 21215164
[TBL] [Abstract][Full Text] [Related]
5. Expression of androgen receptors in primary breast cancer.
Park S; Koo J; Park HS; Kim JH; Choi SY; Lee JH; Park BW; Lee KS
Ann Oncol; 2010 Mar; 21(3):488-492. PubMed ID: 19887463
[TBL] [Abstract][Full Text] [Related]
6. Androgen, estrogen, and progesterone receptor levels in malignant and benign breast tumors: a multivariate analysis approach.
Brentani MM; Franco EL; Oshima CT; Pacheco MM
Int J Cancer; 1986 Nov; 38(5):637-42. PubMed ID: 3770993
[TBL] [Abstract][Full Text] [Related]
7. Does androgen receptor have a prognostic role in patients with estrogen/progesterone-negative and c-erbB-2-positive breast cancer?
Arslan C; Isik M; Guler G; Kulac I; Solak M; Turker B; Ozisik Y; Altundag K
Am Surg; 2012 Sep; 78(9):992-9. PubMed ID: 22964210
[TBL] [Abstract][Full Text] [Related]
8. Differential impact of the expression of the androgen receptor by age in estrogen receptor-positive breast cancer.
Tokunaga E; Hisamatsu Y; Taketani K; Yamashita N; Akiyoshi S; Okada S; Tanaka K; Saeki H; Oki E; Aishima S; Oda Y; Morita M; Maehara Y
Cancer Med; 2013 Dec; 2(6):763-73. PubMed ID: 24403250
[TBL] [Abstract][Full Text] [Related]
9. The expression and prognostic role of EBP1 and relationship with AR in HER2+ breast cancer.
Liu J; Xu C; Xu D; Cao L; Xue H; Meng Q; Niu Y
Virchows Arch; 2020 Aug; 477(2):279-289. PubMed ID: 32086588
[TBL] [Abstract][Full Text] [Related]
10. Expression of Androgen Receptor in Estrogen Receptor-positive Breast Cancer.
Agrawal A; Ziolkowski P; Grzebieniak Z; Jelen M; Bobinski P; Agrawal S
Appl Immunohistochem Mol Morphol; 2016 Sep; 24(8):550-5. PubMed ID: 26230371
[TBL] [Abstract][Full Text] [Related]
11. Distribution, frequency, and quantitative analysis of estrogen, progesterone, androgen, and glucocorticoid receptors in human breast cancer.
Allegra JC; Lippman ME; Thompson EB; Simon R; Barlock A; Green L; Huff KK; Do HM; Aitken SC
Cancer Res; 1979 May; 39(5):1447-54. PubMed ID: 427788
[TBL] [Abstract][Full Text] [Related]
12. Androgen receptor expression shows distinctive significance in ER positive and negative breast cancers.
Tsang JY; Ni YB; Chan SK; Shao MM; Law BK; Tan PH; Tse GM
Ann Surg Oncol; 2014 Jul; 21(7):2218-28. PubMed ID: 24639191
[TBL] [Abstract][Full Text] [Related]
13. Immunohistochemical expression of androgen receptor and prostate-specific antigen in breast cancer.
Narita D; Raica M; Suciu C; Cîmpean A; Anghel A
Folia Histochem Cytobiol; 2006; 44(3):165-72. PubMed ID: 16977795
[TBL] [Abstract][Full Text] [Related]
14. Androgen receptor expression is significantly associated with better outcomes in estrogen receptor-positive breast cancers.
Park S; Koo JS; Kim MS; Park HS; Lee JS; Lee JS; Kim SI; Park BW; Lee KS
Ann Oncol; 2011 Aug; 22(8):1755-62. PubMed ID: 21310761
[TBL] [Abstract][Full Text] [Related]
15. Expression of androgen receptor and its phosphorylated forms in breast cancer progression.
Ren Q; Zhang L; Ruoff R; Ha S; Wang J; Jain S; Reuter V; Gerald W; Giri DD; Melamed J; Garabedian MJ; Lee P; Logan SK
Cancer; 2013 Jul; 119(14):2532-40. PubMed ID: 23605249
[TBL] [Abstract][Full Text] [Related]
16. The expression of calpain-1 and androgen receptor in breast cancer and their correlation with clinicopathological characteristics: An immunohistochemical retrospective study.
Rajković-Molek K; Mustać E; Avirović M; Georgev P; Demaria M; Aničić J; Ban J; Babarović E
Pathol Res Pract; 2020 Sep; 216(9):153068. PubMed ID: 32825941
[TBL] [Abstract][Full Text] [Related]
17. Androgen receptor and metastasis-associated protein-1 are frequently expressed in estrogen receptor negative/HER2 positive breast cancer.
Zhao L; Niu F; Shen H; Liu X; Chen L; Niu Y
Virchows Arch; 2016 Jun; 468(6):687-96. PubMed ID: 27026268
[TBL] [Abstract][Full Text] [Related]
18. Coordinated expression of oestrogen and androgen receptors in HER2-positive breast carcinomas: impact on proliferative activity.
Lin Fde M; Pincerato KM; Bacchi CE; Baracat EC; Carvalho FM
J Clin Pathol; 2012 Jan; 65(1):64-8. PubMed ID: 22039288
[TBL] [Abstract][Full Text] [Related]
19. Adult body size and physical activity in relation to risk of breast cancer according to tumor androgen receptor status.
Zhang X; Eliassen AH; Tamimi RM; Hazra A; Beck AH; Brown M; Collins LC; Rosner B; Hankinson SE
Cancer Epidemiol Biomarkers Prev; 2015 Jun; 24(6):962-8. PubMed ID: 25855627
[TBL] [Abstract][Full Text] [Related]
20. Androgen receptor expression and breast cancer survival in postmenopausal women.
Hu R; Dawood S; Holmes MD; Collins LC; Schnitt SJ; Cole K; Marotti JD; Hankinson SE; Colditz GA; Tamimi RM
Clin Cancer Res; 2011 Apr; 17(7):1867-74. PubMed ID: 21325075
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]